Socio-demographic determinants and effect of structured personal diabetes care:a 19-year follow-up of the randomized controlled study diabetes Care in General Practice (DCGP) by Heltberg, Andreas et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Socio-demographic determinants and effect of structured personal diabetes care
Heltberg, Andreas; Siersma, Volkert; Andersen, John Sahl; Ellervik, Christina; Brønnum-
Hansen, Henrik; Kragstrup, Jakob; Olivarius, Niels de Fine
Published in:
B M C Endocrine Disorders
DOI:
10.1186/s12902-017-0227-x
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Heltberg, A., Siersma, V., Andersen, J. S., Ellervik, C., Brønnum-Hansen, H., Kragstrup, J., & Olivarius, N. D. F.
(2017). Socio-demographic determinants and effect of structured personal diabetes care: a 19-year follow-up of
the randomized controlled study diabetes Care in General Practice (DCGP). B M C Endocrine Disorders, 17, 1-
11. [75]. https://doi.org/10.1186/s12902-017-0227-x
Download date: 03. Feb. 2020
RESEARCH ARTICLE Open Access
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Abstract
Background: We investigated how four aspects of socio-demography influence the effectiveness of an intervention
with structured personal diabetes care on long-term outcomes.
Methods: The Diabetes Care in General Practice (DCGP) study is a cluster-randomized trial involving a population-
based sample of 1381 patients with newly diagnosed type 2-diabetes mellitus. We investigated how education,
employment, cohabitation status and residence influenced the effectiveness of 6 years of intervention with
structured personal diabetes care, resembling present day recommendations. Outcomes were incidence of any
diabetes-related endpoint and death during 19 years after diagnosis, and cardiovascular risk factors, behaviour,
attitudes and process-of-care variables 6 years after diagnosis.
Results: Structured personal care reduced the risk of any diabetes-related endpoint and the effect of the
intervention was modified by geographical area (interaction p = 0.034) with HR of 0.71 (95%CI: 0.60–0.85) and of 1.
07 (95%CI: 0.77–1.48), for patients in urban and rural areas, respectively. Otherwise, there was no effect modification
of education, employment and civil status on the intervention for the final endpoints. There were no noticeable
socio-demographic differences in the effect of the intervention on cardiovascular risk factors, behaviour, attitudes,
and process-of-care.
Conclusion: Structured personal care reduced the aggregate outcome of any diabetes-related endpoint and
independent of socio-demographic factors similar effect on cardiovascular risk factors, behaviour, attitudes and
process of care, but the intervention did not change the existing inequity in mortality and morbidity. Residence
modified the uptake of the intervention with patients living in urban areas having more to gain of the intervention
than rural patients, further investigations is warranted.
Trial registration: ClinicalTrials.gov registration no. NCT01074762 (February 24, 2010).
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Background
Epidemiological studies have repeatedly shown increased
occurrence of type 2 diabetes mellitus (T2DM) among
people with low socioeconomic status [1, 2] and living in
rural areas [3]. Primarily due to improved diabetes care,
mortality of T2DM patients has decreased substantially
in recent decades [4], although this trend has been less
favourable among those with low socio-economic status
(SES) [5–10]. A recent Scandinavian study showed in-
creased mortality among people of low SES, but could
not show any systematic differences in mortality be-
tween patients living in rural and urban areas [8].
Social inequality in mortality and morbidity of pa-
tients with T2DM can only be partially explained by
differences in the increased incidence of other comor-
bid disease [1, 11]. SES has been reported to influence
metabolic control [12], pharmacological treatment [13]
and ability to change lifestyle according to the recommen-
dations [14, 15]. Inequality in access to and utilization of
health care [16, 17] could influence the course of T2DM
[18, 19].
Though SES and place of living influence care and
prognosis of T2DM [8, 10, 11, 20], there is only limited
evidence as to whether the effectiveness of diabetes in-
terventions differs with regard to SES and residence. Re-
cent reports suggest that interventions with intensive
diabetes care diminish the socio-economic differences in
intermediate outcomes [13, 21], but we do not know
whether this effect also is seen on long-term outcomes.
One may hypothesize, that an intervention with struc-
tured personal care may succeed to reduce the difference
between socio-demographic groups [13], as the effective-
ness of this intervention in two post hoc analyses have
been reported to be especially pronounced in women
[22] and in patients with severe mental illness [23].
Our aim in the present study is to describe how socio-
demographic status and residence influences the effect-
iveness of an intervention with structured personal care
in newly diagnosed patients with T2DM regarding all-
cause mortality and any diabetes-related endpoint during
19 years of follow-up.
Methods
Patients
The Diabetes Care in General Practice (DCGP) study
was a pragmatic, open, multicentre, cluster-randomized
controlled trial (ClinicalTrials.gov registration no.
NCT01074762) [18]. The purpose of the trial was to test
whether structured personal care, compared to routine
care, for patients newly diagnosed with T2DM, reduced
the incidence of seven pre-defined outcomes, including
all-cause mortality and any diabetes-related outcome
[18, 24]. In 1988, a random sample of two thirds of Da-
nish general practices, excluding singlehanded practices
with a doctor aged ≥60 years, received an invitation to
participate in the study. Of 1902 general practitioners
(GPs), 474 (25.4%) volunteered. In 1989–1992, all prac-
tices included all patients aged 40 years or over with
newly diagnosed diabetes based on strict criteria [18].
All practices were randomized to either six years of
structured personal care or routine care in the period
1989–1995 and all patients had a follow up examination
6 years after diagnosis [24]. The inclusion criteria were
met by 1590 patients, of which 209 patients were ex-
cluded according to predefined criteria, so that the num-
ber of study participants was 1381 (Fig. 1). Among these
patients, 1369 (99.1%) were of western European descent
and, based on onset of insulin treatment, most were
considered to have T2DM (97.5%). The Ethics Commit-
tee of Copenhagen and Frederiksberg (V.100.869/87) ap-
proved the study and all patients gave informed consent.
Intervention
The Danish healthcare system is mainly tax-financed
and based on the egalitarian principle of equal health-
care access for all equal healthcare needs, clinic visits
are free of charge and expenditures for prescribed drugs
are for the most part reimbursed. In Denmark the GP
usually provides diagnosis and routine care for T2DM
and function as gatekeeper for specialist care.
In the intervention arm follow-up every 3 months and
annual screening for diabetes complications were sup-
ported by sending out a questionnaire to GPs one month
before the next expected consultation. Goal-setting for
blood glucose, blood pressure, lipids and weight was in-
dividualized [24], and GPs were introduced to possible
solutions to therapeutic problems through six annual
half-day seminars, descriptive annual reports on individ-
ual patients as well as folders and leaflets for doctors
and patients, resembling present day recommendations
for diabetes care [25, 26]. None of the intervention pro-
cedures were explicitly based on social differentials. Pa-
tients were never approached by the study centre. GPs
in the routine care group were free to choose any treat-
ment and change it over time [24] and they were not
contacted after patient inclusion had stopped until the
intervention was terminated and the 6-year examination
was initiated in September 1995.
Assessments
At the time of diagnosis and at the 6-year follow up
examination measures of patients’ health and social sta-
tus were collected in questionnaires to GPs, eye doctors
and patients. Upon inclusion, patients gave information
about socio-demographic variables in questionnaires:
highest attained education level (basic school education
only or higher education level); in labour market, out of
labour market or retired; and whether patients lived
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alone or were cohabiting/married. Information on smok-
ing habits and leisure-time physical activity was also col-
lected. Information on place of living was recorded as
rural or urban from area code and population density in
accordance with Statistics Denmark [27].
Clinical and registry based follow-up
The clinical 6-year follow-up examination included meas-
urement of body weight, blood pressure, urinary albumin,
haemoglobin A1c (HbA1c), total cholesterol, fasting triglyc-
erides, and serum creatinine. Patients and doctors were
asked to fill in questionnaires including questions on health
behaviour (smoking, physical activity), attitudes towards
disease (altered habits, diet and home monitoring of blood
glucose), patient’s motivation for best possible control
according to the GP, process-of-care (number of cons-
ultations, number of diabetes-related consultations and
whether patients had been treated at a diabetes clinic) and
if they received pharmacological treatment (cholesterol-
lowering, glucose-lowering and antihypertensive drugs).
During 19 years (mean follow-up time) after diabetes
diagnosis patients were followed up in the national regis-
ters. Vital and emigration status of all patients were certi-
fied through the Danish Civil Registration System [28].
Everyone living in Denmark is registered with a permanent
and unique personal identification number allowing linkage
between study populations and all national registers. Data
on mortality, diagnoses and surgical procedures were from
The Danish Register of Causes of Death (DCD) [29] and
The Danish National Patient Register (DNPR), which
includes information on almost all hospital contacts in
Denmark [30]. The outcomes used in the registry-based
follow up were all-cause mortality and any diabetes-related
endpoint.
(e.g. stroke, myocardial infarction and renal failure, full
list see (Additional file 1)), previously defined [18] and
also used in the UK Prospective Diabetes Study [31].
Statistical analysis
Differences in the incidence of death and any diabetes-
related endpoint between randomization and socio-
demographic groups were analysed univariably with
log-rank tests and multivariably in Cox regressions
models. In the latter, 95% CIs and p values were deter-
mined using a sandwich estimator for the variance to
account for clustering of patients within practices [30].
Absolute risks were calculated as the number of partici-
pants experiencing the corresponding outcome divided
by person years of risk. Two multivariable models are
presented, one adjusted for age at diagnosis, sex and
Primary exclusions:
Severe somatic disease (n=40)
Severe mental illness (n=32)
Declined to consent (n=35)
Secondary exclusions:
Diagnosis not confirmed (n=26)
Primary exclusions:
Severe somatic disease (n=10)
Severe mental illness (n=18)
Declined to consent (n=27)
Secondary exclusions:
Diagnosis not confirmed (n=21)
Withdrew consent to 6-y follow-up (n=18)
Lost to follow-up (n=16)
Died before before 6-y follow-up was 
completed and before 31.01.1998 
(n=178)
Withdrew consent to 6-y follow-up (n=17)
Lost to follow-up (n=18)
Died before before 6-y follow-up was 
completed and before 31.01.1998 
(n=164)
Structured personal care 1989-1995 (n=761) Routine care 1989-1995 (n=620)
Completed 6-y follow-up examination 
26.09.1995 - 31.01.1998 (n=549)
Completed 6-y follow-up examination 
26.09.1995 - 31.01.1998 (n=421)
Registry-based follow-up from diabetes diagnosis and inclusion in study to 31.12.2008
Volunteering general practitioners  (n=474)
Patient recruitment over 2 years (01.03.1989 - 28.02.1991)
71 intervention doctors volunteered to recruit patients for a further year
Randomized to structured personal care (n=243) Randomized to routine care (n=231)
Eligible patients (n=894) Eligible patients (n=696)
Fig. 1 Patient flow diagram from inclusion until 19-year register based follow-up
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clustering, the other with additional adjustment for the
following variables at diagnosis: BMI, hypertension,
HbA1c, total cholesterol, urinary albumin, physical activ-
ity, smoking, known cardiovascular disease (see Table 1),
and prescription of glucose- and/or lipid-lowering and/or
antihypertensive drugs.
For behavioural, clinical, biochemical and process-of-
care variables at the 6-year examination we used multi-
variable generalized linear regression models (ordinary
linear regression for continuous variables, logistic regres-
sion for binary variables and negative binomial regres-
sion for count variables) and presented the effects of
structured care vs. routine care, stratified on sociodemo-
graphic groups adjusted for age, sex, and diabetes dur-
ation. Effect modification was assessed by a test for the
interaction between randomization and SES groups in
the corresponding model. Clustering with GPs was
accounted for by the use of generalized estimating equa-
tions. Due to the multiple comparisons the level of stat-
istical significance at 5% is not interpreted rigorously.
We performed a log rank test for all-cause mortality and
any diabetes-related endpoint comparing the four groups
defined by educational background and the intervention.
We used the statistical program SAS v9.4 (SAS Institute,
Cary, NC, USA).
Results
The indirect randomization was successful except that
relatively more routine care patients were living in rural
areas (Table 1). Overall, a low level of education was as-
sociated with higher all-cause mortality (Fig. 2) and any
diabetes-related endpoint (Fig. 3) showing significant dif-
ference between the 4 groups in respectively all cause-
mortality and any diabetes related endpoint (log-rank
Table 1 Patient characteristics at diabetes diagnosis according to treatment arm
No. of respondents
Routine/
Structured care
Routine
care
Structured
care
p-value
Socioeconomic
Age, years 620/761 65.2 (73.4; 56.2) 65.5 (73.7; 55.6) 0.59
Male gender 620/761 329 (53.1) 404 (53.1) 0.99
Living alone 606/743 198 (32.7) 236 (37.6) 0.72
Rural residence 596/728 161 (27.0) 153 (21.0) 0.011
Basic school education only 588/723 459 (78.1) 574 (79.4) 0.56
Employment status 605/744 0.51
In labor market 157 (26.0) 208 (28.0)
Out of labor marketa 181 (29.9) 203 (27.3)
Retired 267 (44.1) 333 (44.8)
Medical history
Cardiovascular diseaseb 603/743 191 (31.7) 223 (30.0) 0.51
Clinical
Body mass index, kg/m2 619/753 28.7 (32.2; 26.0) 29.4 (33.0; 26.2) 0.21
Hypertensionc 620/761 458 (73.9) 568 (74.6) 0.75
Biochemical
Fasting plasma glucose, mmol/L 620/761 13.8 (10.7; 17.1) 13.6 (10.7; 16.9) 0.44
HbA1c, %
d 512/624 10.2 (8.7; 11.9) 10.2 (8.6; 11.7) 0.75
Total cholesterol, mmol/L 620/740 6.2 (5.5; 7.2) 6.2 (5.3; 7.1) 0.16
Fasting triglycerides, mmol/L 610/736 2.0 (1.4; 3.0) 2.0 (1.4; 2.9) 0.62
Serum creatinine, μmol/L 611/740 88 (79; 100) 90 (80; 101) 0.41
Urinary micro- or proteinuriae 595/723 254 (42.7) 304 (42.1) 0.81
Behavioral
Sedentary (leisure-time) physical activity 604/741 162 (26.8) 210 (28.3) 0.54
Current smokers 604/742 208 (34.4) 264 (35.6) 0.66
Values are medians (interquartile range) or numbers (% of randomization group). The p-values are from Chi square tests for categorical data and Kruskal-Wallis
tests for numeric data. aWelfare benefits (unemployment-, social- health related benefits); bKnown cardiovascular disease: History of myocardial infarction, angina
pectoris, stroke, intermittent claudication or amputation; cPatients with systolic/diastolic BP > 160/90 mmHg and/or the use of antihypertensive and/or diuretic
drugs; dHbA1c measured within 45 days of diabetes diagnosis, reference range 5.4–7.4% (59-81 mmol/mol);
eProtein level in urin > = 15 mg/L
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test, p < 0.0001). During 19 years of registry-based follow
up structured personal care lowered the risk of any
diabetes-related endpoint by 20% compared with routine
care [18], and this effect seems to be most pronounced
for patients living in urban areas (HR(95%CI) 0.71;
0.60–0.85), patients with only basic level of education
(0.75; 0.63–0.89), patients outside the labour market
(0.73; 0.55–0.97) and patients cohabiting (0.78; 0.65–
0.93) (Table 2). The effect of the intervention, however,
was only statistically significantly different between patients
living in urban and rural areas (interaction p = 0.034). The
intervention had no effect on all-cause mortality.
Results describing the role of four different aspects of
socio-demography on behavioural, clinical, biochemical
and process-of-care variables at the 6-year examination
are presented in Additional file 2: Table S1, Additional
file 3: Table S2, Additional file 4: Table S3, Additional
file 5: Table S4, and summarized with the p-values from
the test of the corresponding interaction and a descrip-
tion of the association (Table 3). Overall, the effect of the
intervention on these variables did not differ according to
socio-demography. Only few patients were treated with
cholesterol lowering drugs in 1995–96 (1.9% - 5.8%), but
relatively fewer patients living in rural areas were treated
with cholesterol lowering drugs in response to the in-
tervention compared to urban patients. The intervention
resulted in an increased number of diabetes-related consul-
tations regardless of socio-demographic group, and patients
living alone tended to have relatively more consultations
compared to patients cohabiting.
Discussion
The intervention did not influence all-cause mortality
[18], but overall patients receiving structured personal
care experienced a 20% lower risk of any diabetes-
related endpoint compared to patients receiving routine
care. This effect was greater among patients living in
urban areas compared to rural patients, but otherwise,
there was no effect modification of education, employ-
ment and civil status on the intervention for the final
endpoints. Overall the effect of the intervention on be-
havioural, biochemical and process-of-care measures
was not different between the subgroups of the four as-
pects of socio-demography.
Comparison with existing literature
This study reports social inequity in mortality and
diabetes-related morbidity, in line with other studies that
have investigated the impact of level of education [9],
occupation [8] and socio-economic status [7, 8]. The
present findings suggest that an intervention with struc-
tured personal care does not give rise to more social in-
equity in use of the health care system, as has been
described in other studies [13, 21]. Thus the results do
not confirm results from studies of the general popula-
tion showing that the number of consultations at the GP
increases with decreasing socio-economic status [15, 32].
The fact that socio-economic differences in mortality
and morbidity persist, despite formally equal access to
the public health care system, could be due to different
use of specialist care as suggested by others [17, 20], but
this does not seem to be the case for the intervention in
our study.
Fig. 2 Kaplan-Meier plot showing the proportion of surviving
patients since diabetes diagnosis in patients according to
randomization arm and highest attained education level, only basic
schooling vs. higher
Fig. 3 Kaplan-Meier plot showing the proportion of patients without
any diabetes related endpoint since diagnosis according to
randomization arm and highest attained education level, only basic
schooling vs. higher
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The presented benefit of structured personal care on
long-term endpoints, also for patients with low level of edu-
cation and patients on welfare benefits, cannot be ascribed
to single elements of complex interventions. Patients with
low level of education and income are frequently reported
to be inadequately controlled with hyperglycaemia, hyper-
tension, dyslipidaemia and unhealthy lifestyle [14, 15], and
some studies also suggest socio-demographic differences in
prescription rates [16, 20]. Our results are in line with earl-
ier studies, concerning socio-demographic differences of in-
tensive multifactorial interventions, which have been
shown not to worsen or introduce social inequity in the
control of T2DM [13, 21, 33]. Prior studies suggest that in-
terventions seem to be effective, also among patient with
low SES, in improving cardiovascular risk factors and
prescription of medicine, but it is more difficult to assist
patients in changing lifestyle and attitudes towards DM [13,
21, 33, 34]. As a high-risk group patients with low SES have
potentially more to win [9, 10], but they are also known to
have poor compliance especially regarding lifestyle and atti-
tudes towards DM [5, 14, 15]. The individualization of dia-
betes care in the DCGP trial with negotiation of treatment
goals, taking patient resources in consideration may explain
why this intervention seems to be effective across the
spectrum of SES.
Our results indicate that patients living in rural areas
may have less benefit of the intervention compared to
urban patients. An explanation for this finding could be
Table 3 The effect of structured personal care on behavioral, clinical, process of care and biochemical variables according to socio-
demographic group
Significance (p-value)a of the modification of the intervention effect by the various socio-
demographic variables
Educational
level:
Basic vs. higher
Residence:
Rural vs.
urban
Employment:
Out of labor market vs. in labor
market
Civil status:
Single vs.
cohabiting
Patient attitudesb
Altered habits after diagnosis 0.22 0.08 0.50 0.33
Not full diabetes diet 0.53 0.74 0.78 0.45
Performs home blood/urinary glucose monitoring 0.17 0.89 0.94 0.88
For the patient in question the GP’s opinionb
Patient’s motivation; good or very good for best
possible
control and treatment over past year,
0.34 0.07 0.19 0.80
Clinical
Body mass index 0.29 0.50 0.15 0.65
Systolic blood pressure 0.47 0.23 0.71 0.54
Biochemical
Hemoglobin A1c 0.48 0.31 0.91 0.97
Total cholesterol 0.05(↓) 0.67 0.83 0.79
Serum creatinine 0.42 0.05 (↓) 0.69 0.22
Micro- or proteinuriac 0.81 0.55 0.47 0.92
Behavioralb
Sedentary (leisure time) physical activity 0.90 0.20 0.57 0.67
Current smoking 0.44 0.41 0.56 0.59
Process of careb
Consultations/year 0.93 0.26 0.86 0.53
Diabetes-related consultations/year 0.91 0.18 0.56 0.04 (↑)
Ever treated at diabetic clinic 0.95 0.17 0.87 0.32
Glucose-lowering drugsb 0.26 0.96 0.60 0.33
Antihypertensive drugsb 0.33 0.18 0.55 0.98
Lipid-lowering drugsb 0.82 0.04 (↓) 0.40 0.40
aP-value from a test whether the effect of the intervention differs between socio-demographic groups (e.g. patients with basic school only vs higher education),
adjusted for age, sex and diabetes duration. Clustering with general practice is accounted for by the use of generalized estimating equations. Arrows (↓) indicate
the direction of the effect modification for cases where p < 0.05, e.g. the intervention lowered serum creatinine more in patients living in rural areas than in pa-
tients living in urban areas. bData from questionnaires to patients and their general practitioners. cProteinuria > =15 mg/L
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because the uptake of the intervention was lower among
rural doctors and/or because the compliance with the
intervention among rural patients was low. We could
not see any systematic differences in the 6 year follow
up, on cardiovascular risk factors or behaviour between
urban and rural patients that could reconcile these find-
ing (Table 3). However, our data suggest that rural pa-
tients are less often treated with cholesterol-lowering
drugs as a result of the intervention, but few patients
were actually treated with this medication in the middle
of the 1990s. Other studies have reported that
cholesterol-lowering agents are less often prescribed in
deprived areas [34]. A previous Scandinavian study re-
ported no difference in mortality between urban and
rural patients [8], like our study, other studies have sug-
gested that people residing in more rural areas more
often have undiagnosed diabetes [35, 36]. This implies
that rural patients may be diagnosed at a later stage of
the disease, possibly with a higher risk of complications
and maybe less susceptible to treatment interventions
than patients living in urban areas, this have to be inves-
tigated further.
Strengths and weaknesses of the study
This study contributes to the knowledge on how SES
and urbanisation influence the uptake and effect of dia-
betes interventions and may offer some advantages in
comparison to prior studies. It is a strength of the
present study that it reports hard endpoints after 19 years
of follow up, but on the other hand a limitation that the
results are from an early cohort.
Furthermore, the results are likely to be generalizable
to the wider population of patients with T2DM because
the study was population-based, with no upper age limit,
but also because the study was conducted in general
practice where most T2DM patients are treated. Also,
the elements of the intervention, including the negoti-
ation of treatment goals between patient and doctor, re-
semble standard treatment procedures in current day
general practice diabetes care and recommendations [25,
26]. Finally, the study had a relative high number of GPs
participating and the patient attrition rate was low.
The most important limitation of this study is that it is
a post hoc analysis of a randomized controlled trial.
Since randomization did not take socio-demography into
account, this could have created imbalance between the
randomization groups in relation to socio-demography,
this does not seem to be the case. We although found a
minor difference in randomization regarding residence
that means one should be cautious when interpreting
these results. The fact that we could not describe any
substantial difference between rural and urban patients
at the 6 years clinical follow up – means that the de-
scribed potential difference in effect has to be
investigated further. It is also a limitation that some ele-
ments of the intervention in the structured care arm
were later applied to the routine care arm through na-
tional diabetes guidelines. The intervention could there-
fore prove to be more efficient than reported.
Information on educational level, employment and
civil status were self-reported which might cause mis-
classification, but on the other hand, this information is
readily at hand for the physician. Furthermore, some of
the reported socio-demographic differences in mortality
and morbidity could be due to patients with low level of
education, outside the labour market or living alone
being diagnosed later in the natural history of diabetes
[9, 37] and therefore presenting with a more advanced
disease at diagnosis [13]. Also a higher prevalence of co-
morbidity among patients with low SES in general could
influence the result. We could however only find mo-
derate decline in the association between low soci-
oeconomic status and any diabetes-related endpoint
when adjusting for comorbidity and baseline cardiovas-
cular risk factors, which is in accordance with other
studies [1, 11]. Long-term outcomes were registry-based
and vital status was confirmed for all study participants.
Not all non-fatal outcomes have been tested for validity,
but this is generally considered to be acceptable [29, 30],
and differential misclassification according to treatment
allocation and socio-demography is not expected.
Conclusion
Structured personal diabetes care showed effect on the
aggregate outcome any diabetes-related endpoint, even
for the high-risk group of patients with low level of edu-
cation and patients out of the labour market. Thus,
structured personal care did not give rise to more health
inequality among patients with diabetes but rather a ten-
dency in the opposite direction. Patients living in rural
areas, however, seemed to have gained less from the
intervention compared to patients living in urban areas
this finding has to be investigated further. Still, socio-
economic inequity in mortality and morbidity existed
despite the intervention.
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